That's all sounding very positive (being negative) Chester
Regarding the 12 weeks + Riba
I don't think the EASL would take the $ considerations into account
But somewhere on this site the good doctor has talked of the 'bang for buck' of conventional government funded treatment
12 weeks worth of the new drugs is hideously expensive, whereas Riba is as cheap as chips
So assigning a $ cost to an extra 12 weeks of treatment for only a few more cases of +ve outcomes does not make for a great ROI
For those not previous users of Riba, the low cost to +ve outcomes gives a greater ROI
So as Chester says, it is an individual decision
For my wheezy old liver, an additional 12 weeks can increase my chance of success by 5% (I think i have that correct)
If the price of this is $1500 (as opposed to the exorbitant price the govt would have to pay those swines from Gilead)
Then it is a price worth paying